Showing results (751-760 of 999) with videos related to

Sort By:
Pageof 100
Neuropeptides|May 1, 1984
Preparation of rat brain membranes greatly enriched with either type-I-delta or type-II-delta opiate binding sites using site directed alkylating agents: evidence for a two-site allosteric modelR B Rothman, W D Bowen, V Bykov, et al.
Bioorganic & Medicinal Chemistry Letters|November 15, 2012
6,7-Dihydroxy-1-oxoisoindoline-4-sulfonamide-containing HIV-1 integrase inhibitorsXue Zhi Zhao, Kasthuraiah Maddali, Steven J Smith, et al.
Genome Biology|April 29, 2016
Epigenetic assimilation in the aging human brainGabriel Oh, Sasha Ebrahimi, Sun-Chong Wang, et al.
Chembiochem : a European Journal of Chemical Biology|May 10, 2012
Peptoid-Peptide hybrid ligands targeting the polo box domain of polo-like kinase 1Fa Liu, Jung-Eun Park, Wen-Jian Qian, et al.
Biochemical and Biophysical Research Communications|September 2, 2006
Structure-based design of potent Grb2-SH2 domain antagonists not relying on phosphotyrosine mimicsSheng Jiang, Peng Li, Megan L Peach, et al.
Cancer Research|July 10, 2007
Inhibition of tumor metastasis by a growth factor receptor bound protein 2 Src homology 2 domain-binding antagonistAlessio Giubellino, Yang Gao, Sunmin Lee, et al.
Archives of Biochemistry and Biophysics|March 30, 2004
Phosphotyrosyl peptides and analogues as substrates and inhibitors of purple acid phosphatasesMohsen Valizadeh, Gerhard Schenk, Kevin Nash, et al.
Bioorganic & Medicinal Chemistry Letters|April 14, 2009
Discovery of thioether-bridged cyclic pentapeptides binding to Grb2-SH2 domain with high affinitySheng Jiang, Chenzhong Liao, Lakshman Bindu, et al.
ACS Chemical Biology|February 2, 2012
Identification of high affinity polo-like kinase 1 (Plk1) polo-box domain binding peptides using oxime-based diversificationFa Liu, Jung-Eun Park, Wen-Jian Qian, et al.
Chemical Biology & Drug Design|November 24, 2011
Bicyclic hydroxy-1H-pyrrolopyridine-trione containing HIV-1 integrase inhibitorsXue Zhi Zhao, Kasthuraiah Maddali, Mathieu Metifiot, et al.
Pageof 100